Soluble Guanylate Cyclase Activators and Stimulators in Patients with Heart Failure

被引：0
作者：
Wei-Lin Liang
Bo Liang
机构：
[1] Guangyuan Hospital of Chinese Medicine,Department of Cardiology
[2] Xinqiao Hospital,Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases
[3] Army Medical University (Third Military Medical University),undefined
来源：
Current Cardiology Reports | 2023年 / 25卷
关键词：
Heart failure; Cardiac pharmacology; Soluble guanylate cyclase activators and stimulators; Cinaciguat; Riociguat; Vericiguat; Praliciguat;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：607 / 613
页数：6
相关论文
共 50 条
  • [21] Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP?
    Koress, Cody
    Swan, Kevin
    Kadowitz, Philip
    CURRENT HYPERTENSION REPORTS, 2016, 18 (05)
  • [22] From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators
    Sandner, Peter
    BIOLOGICAL CHEMISTRY, 2018, 399 (07) : 679 - 690
  • [23] Soluble guanylate cyclase: a potential therapeutic target for heart failure
    Gheorghiade, Mihai
    Marti, Catherine N.
    Sabbah, Hani N.
    Roessig, Lothar
    Greene, Stephen J.
    Boehm, Michael
    Burnett, John C.
    Campia, Umberto
    Cleland, John G. F.
    Collins, Sean P.
    Fonarow, Gregg C.
    Levy, Phillip D.
    Metra, Marco
    Pitt, Bertram
    Ponikowski, Piotr
    Sato, Naoki
    Voors, Adriaan A.
    Stasch, Johannes-Peter
    Butler, Javed
    HEART FAILURE REVIEWS, 2013, 18 (02) : 123 - 134
  • [24] Soluble guanylate cyclase: a potential therapeutic target for heart failure
    Mihai Gheorghiade
    Catherine N. Marti
    Hani N. Sabbah
    Lothar Roessig
    Stephen J. Greene
    Michael Böhm
    John C. Burnett
    Umberto Campia
    John G. F. Cleland
    Sean P. Collins
    Gregg C. Fonarow
    Phillip D. Levy
    Marco Metra
    Bertram Pitt
    Piotr Ponikowski
    Naoki Sato
    Adriaan A. Voors
    Johannes-Peter Stasch
    Javed Butler
    Heart Failure Reviews, 2013, 18 : 123 - 134
  • [25] Exploring New Cardiovascular Pathways Are Soluble Guanylate Cyclase Stimulators the Right Direction?
    Michalak, Marek
    Armstrong, Paul W.
    CIRCULATION-HEART FAILURE, 2018, 11 (03)
  • [26] Vericiguat: A Novel Oral Soluble Guanylate Cyclase Stimulator for the Treatment of Heart Failure
    Campbell, Nicole
    Kalabalik-Hoganson, Julie
    Frey, Kathleen
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (05) : 600 - 608
  • [27] Novel Therapies in Heart Failure with Reduced Ejection Fraction: from Soluble Guanylyl Cyclase Stimulators to Cardiac Myosin Activators
    Lampros Papadimitriou
    Gabriel A. Hernandez
    Brandon Lennep
    Robert C. Long
    Javed Butler
    Andreas P. Kalogeropoulos
    Current Treatment Options in Cardiovascular Medicine, 2021, 23 (5)
  • [28] Novel Therapies in Heart Failure with Reduced Ejection Fraction: from Soluble Guanylyl Cyclase Stimulators to Cardiac Myosin Activators
    Papadimitriou, Lampros
    Hernandez, Gabriel A.
    Lennep, Brandon
    Long, Robert C.
    Butler, Javed
    Kalogeropoulos, Andreas P.
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2021, 23 (05)
  • [29] The efficacy and safety of soluble guanylate cyclase modulation in patients with heart failure: a comprehensive meta-analysis of randomized controlled trials
    Arayici, Mehmet Emin
    Gunes, Hakan
    Ellidokuz, Hulya
    Yilmaz, Mehmet Birhan
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [30] Cardiovascular Effects of Stimulators of Soluble Guanylate Cyclase Administration: A Meta-analysis of Randomized Controlled Trials
    Stamerra, Cosimo Andrea
    Di Giosia, Paolo
    Giorgini, Paolo
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (05) : 177 - 187
12345